JMP Securities analyst Jason Butler reiterated a Buy rating on Precigen (PGEN – Research Report) today and set a price target of $13.00. The company's shares closed last Monday at $1.15. According to TipRanks.com, Butler has 0 stars on 0-5 stars ranking scale with an average return of -8.7% and a 33.5% success rate. Butler covers the Healthcare sector, focusing on stocks such as Applied Molecular Transport, Aquestive Therapeutics, and ACADIA Pharmaceuticals. Currently, the analyst consensus on Precigen is a Strong Buy with an average price target of $13.75. See the top stocks recommended by analysts >> The company has a one-year high of $8.
https://www.tipranks.com/news/blurbs/jmp-securities-reiterates-a-buy-rating-on-precigen-pgen?utm_source=advfn.com&utm_medium=referral
Precigen (NASDAQ:PGEN)
Historical Stock Chart
From May 2022 to Jun 2022 Click Here for more Precigen Charts.
Precigen (NASDAQ:PGEN)
Historical Stock Chart
From Jun 2021 to Jun 2022 Click Here for more Precigen Charts.